Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | REII | Common Stock | Award | $24.8K | +275K | +175.61% | $0.09* | 432K | Feb 7, 2022 | Direct | F1 |
transaction | REII | Common Stock | Conversion of derivative security | $10.9K | +156K | +56.46% | $0.07* | 432K | Feb 7, 2022 | Direct | F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | REII | Senior Convertible Promissory Note | Conversion of derivative security | -$10.9K | $0 | Feb 7, 2022 | Common Stock | 156K | $0.07 | Direct | F2 | |||
transaction | REII | Common Stock Purchase Warrant | Award | +575K | 575K | Feb 7, 2022 | Common Stock | 575K | $0.09 | Direct | F1, F3 |
Id | Content |
---|---|
F1 | The grant of both the restricted Common Stock and the Common Stock Purchase Warrant was made in consideration of services to be rendered by the Reporting Person to the Issuer and other consideration set forth in a settlement agreement between the Reporting Person and the Issuer. The restricted Common Stock vests over eight equal quarterly installments, subject to acceleration as set forth in a Restricted Stock Award Agreement. The Common Stock Purchase Warrant vests and becomes exercisable as follows: 1/4 of the underlying shares vest one year from the issue date, and, thereafter, 1/12 of the remaining underlying shares vest on a monthly basis, subject to acceleration as set forth in the Common Stock Purchase Warrant. |
F2 | Each share of Common Stock was issued to the Reporting Person upon conversion of a 10% senior convertible promissory note with total principal and accrued but unpaid interest of $10,902.76. |
F3 | The Common Stock Purchase Warrant is exercisable by the Reporting Person, to the extent vested, for a period of five years from the date of issuance, into shares of common stock of the Issuer, subject to a 9.99% beneficial ownership limitation, at an exercise price of $0.09 per share or by a cashless exercise according to the formula set forth in the Warrant. |